Top Markets
#1 Official Trump Official Trump +42.55%
#2 Melania Meme Melania Meme +20.32%
#3 EXOD EXOD +18.93%
#4 Movement Movement +18.82%
#5 Mubarak Mubarak +18.55%
#6 Wrapped POL Wrapped POL +17.43%
#7 POL (ex-MATIC) POL (ex-MATIC) +17.16%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +16.13%
#9 Unit Pump Unit Pump +11.46%
#10 Pump.fun Pump.fun +11.46%
Coin of the day
Official Trump Official Trump
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Immuno-Biological Laboratories Co., Ltd. Immuno-Biological Laboratories Co., Ltd.

Immuno-Biological Laboratories Co., Ltd.

4570
Classement en actions #24051
Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to... Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to the research, development, production, and distribution of immunological reagents. The company's diverse offerings include ELISA assay kits designed for the precise quantitative measurement of targeted substances, alongside comprehensive research support services focusing on areas such as Alzheimer's disease, metabolic syndrome, and cancer. IBL also caters to specific client needs through customized services for antibody production and the development of bespoke ELISA systems. A prominent service is LipoSEARCH, which provides tailored lipoprotein profiling and analysis utilizing gel-filtration high-performance liquid chromatography. This advanced method allows for the in-depth examination of even minute plasma or serum samples from both humans and small animals, supporting a broad spectrum of research, including lipid metabolism, the creation of pharmaceuticals for lifestyle-related diseases, functional food development, and clinical investigations. For animal health, IBL offers LipoTEST, a diagnostic and health screening tool for veterinary clinics, complemented by personalized biomarker testing services for lifestyle-related conditions. Furthermore, the company operates an innovative protein production division that leverages transgenic silkworms. This technology is instrumental in manufacturing antibodies for research and diagnostic applications, human collagen for cosmetic use, proteins for drug development, and other specialized proteins. Established in 1982, Immuno-Biological Laboratories Co., Ltd. is headquartered in Fujioka, Japan.
Prix de l'action
$7.05
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$65.63M
Changement (1 jour)
-1.64%
Changement (1 an)
117.11%
Pays
JP
Échange Immuno-Biological Laboratories Co., Ltd. (4570)

Catégorie

Healthcare
Bénéfices pour Immuno-Biological Laboratories Co., Ltd. (4570)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Immuno-Biological Laboratories Co., Ltd., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Immuno-Biological Laboratories Co., Ltd. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH